SHOW ME

PRESS
May 20, 2022

OmniLife Named Winner of the 2022 Lyfebulb–CVS Kidney Care® Innovation Challenge

Kindness for Kidneys International Received an Honorable Mention Lyfebulb, a patient-empowerment platform that connects patients with industry …
PRESS
Mar 15, 2022

Lyfebulb and CVS Kidney Care® Announce Finalists for 2022 Innovation Challenge in Kidney Disease

Lyfebulb and CVS Kidney Care®, a CVS Health® (NYSE:CVS) company, are pleased to announce 10 finalists for the 2022 …
PRESS
Jan 4, 2022

Lyfebulb Launches IBDLyfe, a Community Engagement Platform for People Affected by Inflammatory Bowel Disease

Tuesday, January 4, 2022 NEW YORK — Lyfebulb, an online digital platform and community that empowers people …
PRESS
Nov 18, 2021

Loyola University Chicago and Lyfebulb Announce the Winners of the 2021 Innovation Challenge

Katherine Grill, PhD, of Neolth has been selected to receive a $35,000 award, and two runners-up have …
PRESS
Nov 1, 2021

Lyfebulb and CVS Kidney Care® partner to drive innovation and improve access to breakthrough technologies

Monday, November 1, 2021 NEW YORK and WOONSOCKET, RI — Lyfebulb, a patient-empowerment platform that connects patients …
PRESS
Oct 14, 2021

Loyola University Chicago and Lyfebulb Announce 11 Finalists for 2021 Innovation Challenge

They will compete for a total of $75,000 to be distributed among up to three winners CHICAGO …
PRESS
Oct 13, 2021

Lyfebulb Announces Hiring of Digital Product Engineering Team

NEW YORK, Oct. 13, 2021 /PRNewswire/ — Lyfebulb, a patient-empowerment platform that bridges the gap between its patient communities and …
PRESS
Sep 13, 2021

Lyfebulb and Arena Pharmaceuticals Announce the Winner of the 2021 Innovation Challenge in Inflammatory Bowel Disease

Atray Dixit, PhD of Coral Genomics has been selected to receive the $25,000 Innovation Award NEW YORK, …
PRESS
Aug 2, 2021

Loyola University Chicago and Lyfebulb Announce Partnership and Launch 2021 Innovation Challenge Call for Entries

A Total of $75,000 Will Be Distributed to Up to Three Finalists CHICAGO and NEW YORK – …
PRESS
Jun 29, 2021

Lyfebulb and Arena Pharmaceuticals Announce the Finalists for the 2021 Imagining Life Without Limits – An Inflammatory Bowel Disease Innovation Challenge

Finalists will compete for a $25,000 award NEW YORK, NY, USA – June 29, 2021 – Lyfebulb, …
PRESS
May 14, 2021

Lyfebulb and CSL Behring Announce the Winner of the 2021 Transplant Innovation Challenge

Dr. Minnie Sarwal of NephroSant has been selected to receive the $25,000 Innovation Award NEW YORK, NY, …
PRESS
Apr 8, 2021

Lyfebulb and Arena Pharmaceuticals Seek Applicants for the 2021 Imagining Life Without Limits – An Inflammatory Bowel Disease Innovation Challenge

Winning Entry to Receive $25,000 Award NEW YORK, NY, USA – April 8, 2021 – Lyfebulb, a …